Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Cell Biol ; 94(3-4): 148-61, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25681212

RESUMO

The family of lysosome-associated membrane proteins (LAMP) includes the ubiquitously expressed LAMP1 and LAMP2, which account for half of the proteins in the lysosomal membrane. Another member of the LAMP family is LAMP3, which is expressed only in certain cell types and differentiation stages. LAMP3 expression is linked with poor prognosis of certain cancers, and the locus where it is encoded was identified as a risk factor for Parkinson's disease (PD). Here, we investigated the role of LAMP3 in the two main cellular degradation pathways, the proteasome and autophagy. LAMP3 mRNA was not detected in mouse models of PD or in the brain of human patients. However, it was strongly induced upon proteasomal inhibition in the neuroblastoma cell line SH-SY5Y. Induction of LAMP3 mRNA following proteasomal inhibition was dependent on UPR transcription factor ATF4 signaling and induced autophagic flux. Prevention of LAMP3 induction enhanced apoptotic cell death. In summary, these data demonstrate that LAMP3 regulation as part of the UPR contributes to protein degradation and cell survival during proteasomal dysfunction. This link between autophagy and the proteasome may be of special importance for the treatment of tumor cells with proteasomal inhibitors.


Assuntos
Autofagia , Proteínas de Membrana Lisossomal/metabolismo , Proteínas de Neoplasias/metabolismo , Complexo de Endopeptidases do Proteassoma/metabolismo , Fator 4 Ativador da Transcrição/metabolismo , Animais , Encéfalo/metabolismo , Linhagem Celular Tumoral , Humanos , Redes e Vias Metabólicas , Camundongos , Doença de Parkinson/metabolismo
2.
J Neurosci ; 34(41): 13586-99, 2014 Oct 08.
Artigo em Inglês | MEDLINE | ID: mdl-25297088

RESUMO

Parkinson disease (PD) is an α-synucleinopathy resulting in the preferential loss of highly vulnerable dopamine (DA) substantia nigra (SN) neurons. Mutations (e.g., A53T) in the α-synuclein gene (SNCA) are sufficient to cause PD, but the mechanism of their selective action on vulnerable DA SN neurons is unknown. In a mouse model overexpressing mutant α-synuclein (A53T-SNCA), we identified a SN-selective increase of in vivo firing frequencies in DA midbrain neurons, which was not observed in DA neurons in the ventral tegmental area. The selective and age-dependent gain-of-function phenotype of A53T-SCNA overexpressing DA SN neurons was in part mediated by an increase of their intrinsic pacemaker frequency caused by a redox-dependent impairment of A-type Kv4.3 potassium channels. This selective enhancement of "stressful pacemaking" of DA SN neurons in vivo defines a functional response to mutant α-synuclein that might be useful as a novel biomarker for the "DA system at risk" before the onset of neurodegeneration in PD.


Assuntos
Neurônios Dopaminérgicos/fisiologia , Mutação/fisiologia , Estresse Oxidativo/fisiologia , Canais de Potássio Shal/fisiologia , Substância Negra/fisiologia , alfa-Sinucleína/genética , Envelhecimento/fisiologia , Animais , Fenômenos Eletrofisiológicos , Glutationa/metabolismo , Glutationa/fisiologia , Ativação do Canal Iônico/fisiologia , Masculino , Camundongos , Mutação/genética , Substância Negra/citologia , Substância Negra/crescimento & desenvolvimento , Área Tegmentar Ventral/crescimento & desenvolvimento , Área Tegmentar Ventral/fisiologia
3.
Eur J Neurosci ; 40(6): 2898-909, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25059097

RESUMO

The impairment of protein degradation via the ubiquitin-proteasome system (UPS) is present in sporadic Parkinson's disease (PD), and might play a key role in selective degeneration of vulnerable dopamine (DA) neurons in the substantia nigra pars compacta (SN). Further evidence for a causal role of dysfunctional UPS in familial PD comes from mutations in parkin, which results in a loss of function of an E3-ubiquitin-ligase. In a mouse model, genetic inactivation of an essential component of the 26S proteasome lead to widespread neuronal degeneration including DA midbrain neurons and the formation of alpha-synuclein-positive inclusion bodies, another hallmark of PD. Studies using pharmacological UPS inhibition in vivo had more mixed results, varying from extensive degeneration to no loss of DA SN neurons. However, it is currently unknown whether UPS impairment will affect the neurophysiological functions of DA midbrain neurons. To answer this question, we infused a selective proteasome inhibitor into the ventral midbrain in vivo and recorded single DA midbrain neurons 2 weeks after the proteasome challenge. We found a selective increase in the mean in vivo firing frequencies of identified DA SN neurons in anesthetized mice, while those in the ventral tegmental area (VTA) were unaffected. Our results demonstrate that a single-hit UPS inhibition is sufficient to induce a stable and selective hyperexcitability phenotype in surviving DA SN neurons in vivo. This might imply that UPS dysfunction sensitizes DA SN neurons by enhancing 'stressful pacemaking'.


Assuntos
Potenciais de Ação/efeitos dos fármacos , Neurônios Dopaminérgicos/efeitos dos fármacos , Inibidores de Proteassoma/farmacologia , Substância Negra/efeitos dos fármacos , Potenciais de Ação/fisiologia , Animais , Contagem de Células , Morte Celular/efeitos dos fármacos , Neurônios Dopaminérgicos/fisiologia , Comportamento Exploratório/efeitos dos fármacos , Comportamento Exploratório/fisiologia , Lateralidade Funcional , Imuno-Histoquímica , Masculino , Camundongos Endogâmicos C57BL , Microeletrodos , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Oligopeptídeos/farmacologia , Transtornos Parkinsonianos , Substância Negra/fisiopatologia , Tirosina 3-Mono-Oxigenase/metabolismo , Área Tegmentar Ventral/efeitos dos fármacos , Área Tegmentar Ventral/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA